Yadav Mukesh Kumar, Athavale Aakriti, Kumar Sanjay, Singh Roohie, Dutta Anghshuman
Department of ENT, Military Hospital, Hisar, Haryana India.
Present Address: Department of ENT & HNS, Command Hospital Airforce, Bangalore, Karnataka India.
Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3196-3203. doi: 10.1007/s12070-024-04644-5. Epub 2024 Apr 21.
Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder, predominantly affecting the posterior semicircular canal (PSC), and significantly impacts the quality of life (QoL) of patients. This study assesses the effectiveness of Epley's manoeuvre in improving QoL in patients with PSC-BPPV. This prospective analytical study, conducted at a tertiary care centre from January 2021 to December 2022, included 93 adult patients diagnosed with PSC-BPPV via the Dix-Hallpike test. Participants were evaluated using the dizziness handicap inventory (DHI) and visual vertigo analogue score (VAS) at baseline and on days 3, 10, and 30 post-treatments with Epley's manoeuvre. Data analysis focused on changes in DHI and VAS scores to assess the impact of treatment. The cohort comprised 58.1% males and 41.9% females, with a significant majority over 50 years of age. Notably, 90% of patients reported improvement by the first follow-up. Both DHI and VAS scores showed a statistically significant decrease over the follow-up period ( < 0.05), indicating a reduction in perceived dizziness and visual vertigo symptoms post-treatment. Epley's manoeuvre effectively improves the QoL in patients with PSC-BPPV, as evidenced by significant reductions in DHI and VAS scores. This study contributes to the evidence supporting Epley's manoeuvre as a key intervention in PSC-BPPV treatment, emphasizing its role in enhancing patient outcomes in clinical practice.
良性阵发性位置性眩晕(BPPV)是一种常见的前庭疾病,主要影响后半规管(PSC),并对患者的生活质量(QoL)产生重大影响。本研究评估了Epley手法对改善PSC-BPPV患者生活质量的有效性。这项前瞻性分析研究于2021年1月至2022年12月在一家三级医疗中心进行,纳入了93名通过Dix-Hallpike试验诊断为PSC-BPPV的成年患者。在基线以及使用Epley手法治疗后的第3天、第10天和第30天,使用头晕残障量表(DHI)和视觉眩晕模拟评分(VAS)对参与者进行评估。数据分析聚焦于DHI和VAS评分的变化,以评估治疗效果。该队列中男性占58.1%,女性占41.9%,绝大多数患者年龄超过50岁。值得注意的是, 90%的患者在首次随访时报告症状有所改善。在随访期间,DHI和VAS评分均显示出具有统计学意义的下降(<0.05),表明治疗后感知到的头晕和视觉眩晕症状有所减轻。DHI和VAS评分显著降低证明,Epley手法有效地改善了PSC-BPPV患者的生活质量。本研究为支持Epley手法作为PSC-BPPV治疗的关键干预措施提供了证据,强调了其在临床实践中改善患者预后的作用。